pharmaphorum

MARCH 10, 2021

A new focus on “place” and the introduction of medicines registers are among the proposals in a new government white paper on the future of NHS England. Instead, organisations will need to swap top-down market access strategies for a more locally led approach, based on the particular area’s needs and objectives, Thorne believes.

Documentation 59

Documentation Diabetes 59

Pharmaceutical Technology

DECEMBER 8, 2022

According to the revised deal, Daiichi Sankyo and Kite will transfer the Marketing Authorization for Yescarta to Gilead’s Japan subsidiary, Gilead Sciences K.K., The therapy’s sales and promotion works in Japan following the transfer of marketing authorisation will be carried out by the Kite Cell Therapy Business Unit at Gilead Sciences K.K.

Communication 122

Communication Immunity Immunization Hospitals 122

Pharmaceutical Technology

MARCH 10, 2023

The representative expected the facility to open more treatment opportunities for UK citizens saying, “It will help give patients quick access to the latest treatments by increasing the number of UK patients with incurable diseases who are able to take part in clinical trials and bring new treatments into the NHS faster.”

Communication 105

Communication 105

pharmaphorum

MARCH 17, 2022

The uptake of digital health tools during the pandemic has been enormous due to improved access they provide to healthcare. Digital health has a tremendous capacity to transform the healthcare industry, with the ability to provide easy access to a multitude of services and new types of therapies. Whole system approach.

145

145

Pharmaceutical Technology

NOVEMBER 29, 2022

TCR-Ts can detect intracellular targets such as cancer-specific mutations to unlock targets which were not accessible earlier using cell therapies. The takeover will offer AstraZeneca access to TCR-Ts, which possess the potential for fighting solid tumours.

Communication 111

Communication 111

Pharmaceutical Technology

DECEMBER 12, 2022

The development, clinical trial and marketing expenses for the cell therapy will be shared by the companies while co-commercialising the product and equally splitting profits from the US region. Kite will oversee the marketing of the product outside the US while Arcellx is eligible for royalty payments on sales.

Communication 105

Communication 105

Integra X Files

MARCH 6, 2023

The challenge is to find the time and resources to manage a marketing program while continuing to fully serve existing clients. Allocating a marketing budget will help. A Look at Your Pharmacy’s Market Have you taken time for a deep look at your competitors and potential new customers? to 5% of total revenue on marketing.

Assisted Living 81

Assisted Living Nursing Homes 81

Pharmaceutical Technology

JANUARY 5, 2023

Capsida Biotherapeutics CEO Peter Anastasiou said: “Prevail’s expertise in neuroscience, gene therapy R&D, and access to Lilly’s world-class commercialization capabilities complements Capsida’s fully integrated approach, including our next-generation AAV engineering platform.

Communication 95

Communication 95

Drug Channels

FEBRUARY 23, 2021

In this issue: Payers confess: Patients lose from copay accumulators Humana joins the Express Scripts GPO Hospitals vs. PBMs over specialty pharmacy white bagging Let’s all follow the Buy-and-Bill Dollar! For background, see Express Scripts + Prime Therapeutics: Our Four Takeaways From This Market Changing Deal. More to come.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Independent Pharmacies Online Pharmacies 52

pharmaphorum

NOVEMBER 20, 2020

Gordon joins Prescient with more than 15 years of dedicated oncology experience in market research and competitive intelligence. He has an MBA in market and strategy from Carnegie Mellon University and a BA in biochemistry from the University of Pennsylvania.

Medical Schools 69

Medical Schools 69

Quality Matters

OCTOBER 24, 2023

Mitigating Cancer Drug Shortages: USP-American Cancer Society Summit Issues Call to Action Patient access to cancer drugs can mean the difference between life and death. Persistent shortages threaten patients’ access to the lifesaving and life-sustaining therapies they need. 26 by the U.S. That’s up from 168 in 2011, Kleinrock noted.

Chemotherapy 64

Chemotherapy Hospitals 64

Pharmaceutical Technology

JANUARY 11, 2023

AbbVie will get exclusive rights to license and develop and market the programmes. By downloading this Whitepaper, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Communication 59

Communication 59

Pharmaceutical Technology

MARCH 1, 2023

The deal offers access to the platforms of Tevard to discover and develop tRNA-based therapies. Tevard Biosciences and Vertex Pharmaceuticals have announced a four-year global research partnership to develop new tRNA-based therapies to treat Duchenne muscular dystrophy (DMD) patients.

Communication 52

Communication 52

Pharmaceutical Technology

JULY 28, 2022

By carefully weighing up a range of factors, businesses can ensure they are choosing a city or region where their company can access the resources needed to scale multinational operations smartly. Domestic market and transportation infrastructure. Locations with access to the sea may also offer a cheaper way of transporting goods.

Research Laboratories 52

Research Laboratories Pharmaceutical Manufacturing 52

Quality Matters

FEBRUARY 9, 2023

Increasing capacity will also help the continent respond to future health emergencies, provide more treatment options to patients, diversify markets, shorten medical supply chains, and spur economic growth. For more information, see the full white paper martin_laura Thu, 02/09/2023 - 13:25 Global Health

Vaccines 52

Vaccines Immunity Immunization Labelling 52

pharmaphorum

MARCH 30, 2021

When you’re bringing a transformational therapy to market, you have to think quite differently about it. These include perceptions of transformational therapies as ‘unaffordable’ and the often-limited evidence available when ground-breaking treatments come to market sometimes on the basis of phase 2 data alone. “If

Communication 83

Communication Labelling 83

Pharmaceutical Technology

JANUARY 20, 2023

According to the website, Moderna’s mRNA access program intends to “accelerate the creation of new vaccines using mRNA technology in collaboration with global partners”. During the panel, Bancel discussed plans to get mRNA vaccines for the 15 high priority viruses, as identified by the WHO, into the clinic.

Vaccines 98

Vaccines Communication 98

PharmaState Academy

AUGUST 9, 2023

Written By: Vivek Hattangadi Crimes in Copywriting – Part 2 Styles Of Copywriting for Medico-Marketing: Know The 6 Most Important! The goal of medico-marketing copywriting is to build up the reputation of your brand and elicit an action from doctors. So also “What is the goal of your medico-marketing copy.”

Health and Personal Care Stores 52

Health and Personal Care Stores Communication Diabetes 52

pharmaphorum

SEPTEMBER 18, 2020

The Transformational Value: Preparing for a Decade of Radical Change white paper from the Adelphi Group sets out the key tenets of the concept and the opportunity for pharma to take a big picture view of ‘transformational value’ and how to respond to it. The post Preparing for a decade of radical change in pharma appeared first on.

115

115

PharmaKinnex

APRIL 13, 2022

Pharma Marketing Solutions That Help Address Whitespace April 13, 2022. Whitespace in pharma marketing refers are areas where pharma companies don’t add a field salesforce presence in because of the lack of ROI caused by smaller population size and lower sales potential for each physician. Inside Sales – Unlimited Possibilities.

Medical Records 52

Medical Records Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

Pharmaceutical Technology

MARCH 10, 2023

The virtual company creation of Cell One Partners helps in removing the barriers to access to senior C-suite leadership by providing virtual management at one-third of the cost of a traditional new start-up company. This allows the asset owners to focus their cash and energies on research and development.

Communication 98

Communication 98

pharmaphorum

JUNE 29, 2022

The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth. COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026.

HIV Treatment and Prevention Agents 57

HIV Treatment and Prevention Agents Vaccines Pharmaceutical Companies Pharmaceutical Companies 57

The Thyroid Pharmacist

OCTOBER 7, 2022

In my past life, I would put three teaspoons of (white, refined) sugar in my tea. I knew from papers that I read in pharmacy school, that artificial sweeteners were toxic. Several stevia products currently on the market are USDA-certified organic.). Accessed September 27, 2022. You need to cut out the sugar.”.

Diabetes 95

Diabetes Immunity Immunization Labelling 95

Pharmaceutical Technology

FEBRUARY 28, 2023

More than 100 treatments are currently on the market, with hundreds more on their way. However, costs need to fall to improve access to these life-saving therapies. To learn more about how the 3M Harvest RC Chromatographic Clarifier is revolutionising biopharma production, download this specially commissioned white paper.

Documentation 94

Documentation Communication 94

pharmaphorum

FEBRUARY 1, 2021

Italy was working up big changes in market access throughout 2020 which will be implemented in 2021. In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring for market access in Italy. Italy operates two special funds for innovative medicines.

Biosimilars 52

Biosimilars Hospitals 52

pharmaphorum

SEPTEMBER 13, 2022

Thanks to the dedicated efforts of doctors, patients, carers, and healthcare professionals, people diagnosed with blood cancer are now living longer, with a steady stream of more effective treatments entering the market each year. 1847 – Virchow links tumours and white blood cells. 1844 – First reported case of multiple myeloma.

Chemotherapy 98

Chemotherapy Immunity Immunization Documentation 98

Pharmaceutical Technology

MARCH 22, 2023

Patients living with cancer and Alzheimer’s are two examples of groups that need access. By increasing productivity, manufacturing costs are reduced, which also offers the opportunity to expand access for biotherapeutics to more patients living with serious and chronic diseases.

Documentation 52

Documentation Communication 52

Quality Matters

NOVEMBER 10, 2022

In fact, USP is developing a suite of analytical lab services – which we call R&D analytical solutions – for manufacturers to help drive PCM innovation, contain production costs, and optimize efficiencies in staffing and resources while facilitating market access to quality medicines made with PCM technology.

Drug Development 52

Drug Development 52

Pharmaceutical Technology

FEBRUARY 1, 2023

The first RSV vaccine to enter the market will access a first-mover advantage and capture 100% of the market share, says Nancy Jaser, senior infectious disease analyst at GlobalData. Among the many competitors in this space, seven companies are in Phase III trials and some may face regulatory decisions in 2023.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

pharmaphorum

JANUARY 14, 2021

The promotional environments of major pharmaceutical markets were already divergent in 2019 – some, like Italy and Spain were very high on traditional face to face interactions, others, like the UK, were the complete opposite, and still others, like Japan and the US, had high volumes of both digital and face to face contacts.

Biosimilars 70

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Labelling 70

Putting Patients First Blog

APRIL 14, 2023

We promote increased access to affordable, high-value, equitable, and sustainable health care. As a patient advocacy organization whose mission is to promote increased patient access to affordable, high-value, sustainable, and equitable health care, we submit these comments regarding the impact of the negotiation program on patients.

Drug Pricing 40

Drug Pricing Drug Development Documentation Communication 40

Putting Patients First Blog

JUNE 30, 2023

We promote increased access to affordable, high-value, sustainable health care. No mention was provided in the proposed changes nor the white paper on Advancing Health Technology Assessment Methods that Support Health Equity of clinical trial participants with differential abilities.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Drug Development 40

Putting Patients First Blog

NOVEMBER 14, 2023

We promote increased access to affordable, high-value, equitable, and sustainable health care. According to a 2017 report by the National Council on Disability, individuals with disabilities often face significant barriers in accessing health care services, including discriminatory attitudes from health care.9

Communication 40

Communication Bioethics Hospitals Documentation 40

FDA Law Blog: Biosimilars

JANUARY 24, 2024

Fast-forward to March 2023, when The White House OSTP issued a document per Executive Order 14081, titled “ Bold Goals for U.S. If this vision is achieved, the United States can bring innovative biotechnologies and products to markets faster while building a more robust supply chain ecosystem. drug supply chain.

Documentation 69

Documentation 69

Pharmaceutical Technology

DECEMBER 9, 2022

Brazil is the largest country in Latin America, with a population of over 212 million, and consequently has the biggest pharmaceutical market in the region. Advantages of joining PIC/S include the adoption of codes that should reduce the number of audits required for some products, accelerating their time to market.

Drug Pricing 98

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 98

Pharmaceutical Technology

MARCH 17, 2023

These agreements have been particularly propelled by the recent rise in inflationary pressures and pharmaceutical market instability, pushing healthcare systems to find new ways to reduce risks associated with new drugs. Thus, a higher risk score reflects a more hostile market access environment and drug launch in a geographical area.

Communication 102

Communication Pharmaceutical Companies Pharmaceutical Companies 102

Pharmaceutical Technology

MAY 3, 2023

First generics are the first opportunity manufacturers have to market new generic drug products in the US. In recent years, first generics have improved patient access to essential treatments and offered affordable treatment options for patients with multiple sclerosis, asthma, heart disease, diabetes, and even the flu.

Generic Medicine 98

Generic Medicine Drug Development Diabetes Communication 98